News & Announcements
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
- CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology - Precision NanoSystems will lead RNA vaccine formulation development - CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials Tianjin, China and Vancouver, Canada – CanSin [...]
Nivagen Pharmaceuticals Closes $16 Million Growth Equity Financing from Telegraph Hill Partners
Additional Resources Will Support Product Development and Expansion of Manufacturing Capabilities Sacramento, Calif.—(May 19, 2020)—Nivagen Pharmaceuticals, Inc. (“Nivagen”), a specialty pharmaceuticals company, announced the closing of a $16 million equity financing round led by Telegraph Hill Pa [...]
Nimble announces collaboration to discover and develop novel peptide-based compounds for SARS-CoV-2 diagnostics
MADISON, WI--Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays. Nimble will extend its proprietary peptide synthesis, screening and optimization platfo [...]
Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble’s Novel Biomarker Discovery Engine
MADISON, WI, USA and Malmö, SE -- Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble’s powerful and broadly applicable biomarker discovery engine and Svar’s strong in vitro diagnostic test development and [...]
Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer
Vancouver BC, April 8, 2020 Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the company’s Chief Scientific Officer (CSO). Dr. Geall has over 20 years’ experience in the development of drug delivery systems [...]
Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
Funded by the Bill and Melinda Gates Foundation, CoVIC Seeks to Find Therapeutic Candidates for COVID-19 in Just Weeks Salt Lake City, Utah and La Jolla, California, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization tools, and La Jolla Institute for Imm [...]
Dynex® Technologies Assisting in the Fight Against COVID-19
Dynex’s portfolio of open, automated microplate instruments, with a global distribution network and footprint, demonstrates ability to support COVID-19 testing worldwide. CHANTILLY, VA March 27, 2020 – Dynex Technologies, Inc., announced today that it is actively working with leading ELISA test kit [...]